Bioscience Today - Issue 29
Chemical Industry Journal
Shedding light on the stories that shape the future of the UK chemical industry and supply chain.
The latest issue of our sister publication Bioscience Today is out now. Here is a snapshot of?Issue 29's top stories:
Defining the future of experiment design
Currently digitilisation of life science R&D is very fragmented, with experiment design using a range of platforms and scientific collaborations which are neither efficient nor cost-effective. Imagine then adding coding to the mix. There’s no need for coding with our operating platform, say the Synthace team… it’s as easy as dragging and dropping!
Healing the pharma supply chain: how the industry can outsmart disruption
The pharmaceutical industry fared relatively well through the pandemic, with few manufacturing sites being closed due to infections. It may come as some surprise, then, that the sector has recently hit rockier ground. A supply chain shortage has come to light, leaving many patients struggling to access pain relief, oncology medication, antihistamines, hormone replacement therapy, anticlotting agents, and other important drugs.
Neurons are caught rapidly switching gears
Even during such routine tasks as a daily stroll, our brain sometimes needs to shift gears, switching from navigating direction to avoiding traffic or crossing the street to see a friend. These switches pose a challenge: How do the brain’s circuits deal with such dynamic and abrupt changes in behavior? A Weizmann Institute of Science study on bats, published in?Nature, suggests an answer that does not fit the classical thinking about brain function.
Synthetic mouse embryo models created from stem cells
An egg meets a sperm — the necessary first step for life and a common first step in embryonic development research. But now researchers have grown synthetic embryo models of mice outside the womb with stem cells cultured in a petri dish – without using fertilised eggs.